CY1119360T1 - Εκχυλισμα πιτουρου σπορου απο κοϊξ-δακρυ του ιωβ και χρηση αυτου - Google Patents

Εκχυλισμα πιτουρου σπορου απο κοϊξ-δακρυ του ιωβ και χρηση αυτου

Info

Publication number
CY1119360T1
CY1119360T1 CY20171100883T CY171100883T CY1119360T1 CY 1119360 T1 CY1119360 T1 CY 1119360T1 CY 20171100883 T CY20171100883 T CY 20171100883T CY 171100883 T CY171100883 T CY 171100883T CY 1119360 T1 CY1119360 T1 CY 1119360T1
Authority
CY
Cyprus
Prior art keywords
tear
lobster
interleukin
extract
cobx
Prior art date
Application number
CY20171100883T
Other languages
English (en)
Inventor
Huang-Chung Tseng
Giao-Zhi Huang
Tung-An Chia
Original Assignee
Joben Bio-Medical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joben Bio-Medical Co., Ltd. filed Critical Joben Bio-Medical Co., Ltd.
Publication of CY1119360T1 publication Critical patent/CY1119360T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μια σύνθεση η οποία περιλαμβάνει εκχύλισμα πίτουρου από δάκρυ του Ιώβ, όπου το εκχύλισμα πίτουρου από δάκρυ του Ιώβ περιλαμβάνει εκχύλισμα πίτουρου από δάκρυ του Ιώβ με C1 έως C7 αλκοόλη (Α) και εκχύλισμα πίτουρου από δάκρυ του Ιώβ με υπερκρίσιμο ρευστό διοξείδιο του άνθρακα (Β). Κατά προτίμηση, το εκχύλισμα πίτουρου από δάκρυ του Ιώβ έχει αποτελέσματα σε αντιμετώπιση μιας νόσου του δέρματος και/ή του υποδόριου ιστού και σε μείωση ιντερλευκίνης (ΙL)-1α, ιντερλευκίνης-1β, ιντερλευκίνης-6, παράγοντα νέκρωσης όγκων (TNF)-α, ιντερλευκίνης-8, προσταγλανδίνης-2(PGE2) και/ή C-Αντιδρώσας Πρωτεΐνης (CRP).
CY20171100883T 2012-12-20 2017-08-21 Εκχυλισμα πιτουρου σπορου απο κοϊξ-δακρυ του ιωβ και χρηση αυτου CY1119360T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/086998 WO2014094269A1 (zh) 2012-12-20 2012-12-20 薏苡子麸皮的萃取物及其应用

Publications (1)

Publication Number Publication Date
CY1119360T1 true CY1119360T1 (el) 2018-02-14

Family

ID=50977560

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100883T CY1119360T1 (el) 2012-12-20 2017-08-21 Εκχυλισμα πιτουρου σπορου απο κοϊξ-δακρυ του ιωβ και χρηση αυτου

Country Status (13)

Country Link
EP (1) EP2937095B1 (el)
JP (1) JP6029770B2 (el)
CY (1) CY1119360T1 (el)
DK (1) DK2937095T3 (el)
ES (1) ES2638149T3 (el)
HR (1) HRP20171171T1 (el)
HU (1) HUE034481T2 (el)
LT (1) LT2937095T (el)
PL (1) PL2937095T3 (el)
PT (1) PT2937095T (el)
RS (1) RS56192B1 (el)
SI (1) SI2937095T1 (el)
WO (1) WO2014094269A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102563015B1 (ko) * 2020-11-20 2023-08-04 대구한의대학교산학협력단 새싹율무 열수 추출물을 이용한 궤양성 대장염의 예방 또는 치료

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072123A1 (fr) * 2001-03-02 2002-09-19 Beppu, Kunihide Compositions prophylactiques ou therapeutiques pour des maladies tumorales ou liees au papillomavirus
CN1234828C (zh) * 2002-11-21 2006-01-04 上海高科联合生物技术研发有限公司 超临界二氧化碳萃取薏苡仁油的方法
CN1778380A (zh) * 2004-11-23 2006-05-31 乔志亚生技股份有限公司 薏仁油萃取的方法及组成分及其疗效
CN101189988B (zh) * 2006-11-20 2010-09-29 乔志亚生技股份有限公司 可降低血脂与低密度胆固醇的薏仁油的浓缩方法
CN102177978B (zh) * 2011-04-14 2013-01-30 西南大学 薏苡仁米糠及其运用

Also Published As

Publication number Publication date
ES2638149T3 (es) 2017-10-18
SI2937095T1 (sl) 2017-12-29
HUE034481T2 (en) 2018-02-28
JP2016505577A (ja) 2016-02-25
PL2937095T3 (pl) 2017-11-30
DK2937095T3 (en) 2017-09-11
EP2937095A1 (en) 2015-10-28
EP2937095B1 (en) 2017-06-07
JP6029770B2 (ja) 2016-11-24
PT2937095T (pt) 2017-08-29
WO2014094269A1 (zh) 2014-06-26
HRP20171171T1 (hr) 2017-10-20
RS56192B1 (sr) 2017-11-30
LT2937095T (lt) 2017-09-11
EP2937095A4 (en) 2015-12-16

Similar Documents

Publication Publication Date Title
EA201690421A1 (ru) Положительный эффект в форме увеличения продолжительности жизни у больных с солидными опухолями с повышенными уровнями c-реактивного белка
EA201270571A1 (ru) Человеческие il-23-антигенсвязывающие белки
BR112013010857A2 (pt) imonoglubulinas de duplo domínio variável e usos das mesmas
CR20130134A (es) Inmunoglobulinas con dominio variable dual y usos de las mismas
EA201591427A1 (ru) Соединения и их применения для модуляции гемоглобина
AR107735A1 (es) MOLÉCULAS DE ANTICUERPOS MULTIESPECÍFICAS QUE TIENEN ESPECIFICIDAD POR FACTOR DE NECROSIS TUMORAL a (TNF-a), INTERLEUCINAS: IL-17A E IL-17F
EA201300558A1 (ru) Соединения и способы для купирования боли
BR112013029800A2 (pt) tratamento de degeneração do disco intervertebral com o uso de células derivadas do tecido do tecido do cordão umbilical humano
TR201908777A2 (tr) Suda Çözünür ve Suda Çözünür Olmayan Özellikte Yüksek Antioksidan Kapasitesine Sahip Propolis Ürünleri ve Üretim Yöntemi
EA201170965A1 (ru) Усовершенствованные вакцины вируса человеческой папилломы и способы их использования
CY1124191T1 (el) Θεραπεια της νοσου μοσχευματος εναντια στον ξενιστη σε μεταμοσχευμενους ασθενεις
MX2016005824A (es) Metodo de cultivo celular.
SG11201804755VA (en) Method for manufacturing tissue/organ by using blood cells
CY1119360T1 (el) Εκχυλισμα πιτουρου σπορου απο κοϊξ-δακρυ του ιωβ και χρηση αυτου
RU2016146567A (ru) Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты
RU2018107704A (ru) Средство, содержащее аттрактант жировых стволовых клеток, для улучшения рыхлости или старения кожи, вызываемых образованием дермальных полостей
CL2019003459A1 (es) Métodos de cultivo celular.
BR112016028561A2 (pt) composição, forma de dosagem, e, métodos para reduzir o risco para mortalidade em um indivíduo, o risco para uma doença ou condição em um indivíduo, triglicerídeos em um sangue de indivíduo, a frequência cardíaca em repouso de um indivíduo, o colesterol de lipoproteína de densidade não alta em um indivíduo, o colesterol total em um indivíduo, a apolipoproteína b em um sangue de indivíduo, pressão sanguínea sistólica em um indivíduo e a pressão sanguínea diastólica em um indivíduo, para prolongar a vida de um indivíduo, para tratar hipertrigliceridemia em um indivíduo e para aumentar um índice de ômega-3 em células vermelhas do sangue de um indivíduo.
EA201490201A1 (ru) Выявление экспрессии гена prame при раковом заболевании
CR20130577A (es) Producto de proteínas y proceso para la fabricación de un producto de proteínas a partir de exudado de carne cruda
EA201490758A1 (ru) Вакцины против вируса человеческой папилломы и способы их применения
Kobak et al. SERUM GALECTIN-3 AND TGF-BETA LEVELS IN PATIENTS WITH SARCOIDOSIS
RU2012138835A (ru) Способ получения очищенного соматического антигена dirofilaria immitis
CY1119117T1 (el) Δερμοπροστατευτικη και δερμο-εξισορροπητικη συνθεση
Terentieva et al. Clinical results of application PRP after tonsillectomy performed under the local anestesy